Fox Hill Wealth Management »

Sarepta Therapeutics note 1.500% 11/1 shares owned by Fox Hill Wealth Management

Quarter-by-quarter ownership of Sarepta Therapeutics note 1.500% 11/1 shares owned by Fox Hill Wealth Management from 13F filings

Historical chart of Fox Hill Wealth Management investment in Sarepta Therapeutics note 1.500% 11/1

Tip: Access up to 7 years of quarterly data

All positions including Sarepta Therapeutics note 1.500% 11/1 held by Fox Hill Wealth Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Sarepta Therapeutics note 1.500% 11/1 by Fox Hill Wealth Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $43k 24k 1.78
2023-12-31 $32k 23k 1.40

More positions owned by Fox Hill Wealth Management

Microsoft Corporation (MSFT)
Eli Lilly & Co. (LLY)
Apple (AAPL)
NVIDIA Corporation (NVDA)
Costco Wholesale Corporation (COST)
Adobe Systems Incorporated (ADBE)
Amazon (AMZN)
Meta Platforms Cl A (META)
Novo-nordisk A S Adr (NVO)
Spdr Gold Tr Gold Shs (GLD)
Crowdstrike Hldgs Cl A (CRWD)
Norfolk Southern (NSC)
Netflix (NFLX)
Arista Networks (ANET)
Berkshire Hathaway Inc Del Cl B New (BRK.B)

View all positions for Fox Hill Wealth Management

Top funds holding Sarepta Therapeutics note 1.500% 11/1

DLD Asset Management
Point72 Asset Management
D. E. Shaw & Co
CSS
Capstone Investment Advisors
Boothbay Fund Management
FMR
Warberg Asset Management
Palisade Capital Management
Wolverine Asset Management
Bnp Paribas Arbitrage, Snc
Morgan Stanley
Fox Hill Wealth Management
Virtus Investment Advisers
Jpmorgan Chase & Co

View all funds holding Sarepta Therapeutics note 1.500% 11/1